Letter to the Editor
Sir: It is widely believed that antimanic efficacy with lithiumrequires doses at a level sufficient to achieve blood levels > 0.7mEq/L, although few data exist about bipolar patients who mayrespond to doses producing lower serum levels. In addition, asanticonvulsant mood stabilizers enter wider use, little is knownabout whether some bipolar patients respond preferentially tolithium or to combinations of lithium and anticonvulsants. Wereport 2 cases of geriatric mania that occurred after lithium discontinuationdue to neurotoxicity.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
This PDF is free for all visitors!